licence for the lumpy skin disease (LSD) vaccine for dairy cattle and buffaloes Biolumpivaxin it developed in collaboration with Indian Council of Agriculture Research (ICAR). As the first ...

An employee of the animal husbandry department administrating lumpy skin disease vaccine to a cow in Chandigarh. (HT Photo) Animal husbandry department secretary Hari Kallikkat said in the third ...

Animal health vaccine maker Biovet, a Bharat Biotech group firm, announced on Monday that it has received approval from the Central Drug Standards Control Organization (CDSCO) for its lumpy skin ...

Biovet, a part of Bharat Biotech, on Monday said it has received approval from the Central Drug Standards Control Organisation (CDSCO) to market a vaccine for lumpy skin disease (LSD) in dairy ...

Biolumpivaxin will help in disease surveillance as it means the experts will be able to distinguish between vaccinated and ...

The firm has claimed that it is the first such vaccine in the world for the highly infectious viral disease that affects ...

However, some tumors can affect skin due to hormonal changes. Persistent skin changes or unusual lumps may warrant medical ... changes may indicate other skin diseases or in the worst case ...

Biovet, a part of Bharat Biotech, has received approval to market Biolumpvaxin, a groundbreaking DIVA marker vaccine for lumpy skin disease in cattle and buffaloes. The launch of this vaccine marks a ...

An outbreak of lumpy skin disease among cattle has been confirmed in the Epukiro veterinary district in the Omaheke Region of Namibia. According to acting veterinary officer Dr Johanner Shoopala, 73 ...

Biovet, a subsidiary of Bharat Biotech, has received approval from CDSCO for its lumpy skin disease vaccine, Biolumpvaxin, marking a significant step towards India's veterinary healthcare ...

New Delhi: The Central Drug Standards Control Organisation (CDSCO) has granted license to Biolumpivaxin, the country’s first vaccine against lumpy skin disease (LSD) in dairy cattle and buffaloes, ...

This vaccine offers a high safety and efficacy profile while enabling serological differentiation between naturally infected and vaccinated animals with the DIVA concept in it.